BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3728146)

  • 1. Deficiency of erythrocyte type isozyme of AMP deaminase in human.
    Ogasawara N; Goto H; Yamada Y; Hasegawa I
    Adv Exp Med Biol; 1986; 195 Pt A():123-7. PubMed ID: 3728146
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficiency of AMP deaminase in erythrocytes.
    Ogasawara N; Goto H; Yamada Y; Nishigaki I; Itoh T; Hasegawa I; Park KS
    Hum Genet; 1987 Jan; 75(1):15-8. PubMed ID: 3804327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete deficiency of AMP deaminase in human erythrocytes.
    Ogasawara N; Goto H; Yamada Y; Nishigaki I; Itoh T; Hasegawa I
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1344-9. PubMed ID: 6477565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of AMP deaminase in human erythrocytes.
    Zydowo MM; Purzycka-Preis J; Ogasawara N
    Adv Exp Med Biol; 1989; 253A():31-4. PubMed ID: 2624209
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of D-ribose in myoadenylate deaminase deficiency.
    Lecky BR
    Lancet; 1983 Jan; 1(8317):193. PubMed ID: 6130241
    [No Abstract]   [Full Text] [Related]  

  • 6. Myoadenylate deaminase deficiency: diagnosis by forearm ischemic exercise testing.
    Valen PA; Nakayama DA; Veum JA; Wortmann RL
    Adv Exp Med Biol; 1986; 195 Pt B():525-8. PubMed ID: 3766241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP deaminase isozymes in human blood cells.
    Ogasawara N; Goto H; Yamada Y
    Adv Exp Med Biol; 1984; 165 Pt B():59-62. PubMed ID: 6720452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent loss of adenosine 5'-monophosphate deaminase activity may explain elevated adenosine 5'-triphosphate levels in senescent erythrocytes.
    Dale GL; Norenberg SL
    Blood; 1989 Nov; 74(6):2157-60. PubMed ID: 2804354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoadenylate deaminase deficiency: a new disease of muscle.
    Fishbein WN; Armbrustmacher VW; Griffin JL
    Science; 1978 May; 200(4341):545-8. PubMed ID: 644316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive myalgias and polyarthralgias in a patient with myoadenylate deaminase deficiency.
    Lally EV; Friedman JH; Kaplan SR
    Arthritis Rheum; 1985 Nov; 28(11):1298-302. PubMed ID: 4063004
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic distinction of human muscle adenylate deaminase from the isoenzyme(s) in human peripheral blood cells: implications for myoadenylate deaminase deficiency.
    Fishbein WN; Davis JI; Nagarajan K; Winkert JW; Foellmer JW
    Arch Biochem Biophys; 1980 Dec; 205(2):360-4. PubMed ID: 6781410
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of AMP deaminase isozymes in various human blood cells.
    Ogasawara N; Goto H; Yamada Y; Watanabe T
    Int J Biochem; 1984; 16(3):269-73. PubMed ID: 6698294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deamination of adenosine and adenosine monophosphate in Plasmodium falciparum-infected human erythrocytes: in vitro use of 2'deoxycoformycin and AMP deaminase-deficient red cells.
    Roth E; Ogasawara N; Schulman S
    Blood; 1989 Aug; 74(3):1121-5. PubMed ID: 2665862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase activity in a series of 19 patients with the Diamond-Blackfan syndrome.
    Whitehouse DB; Hopkinson DA; Pilz AJ; Arredondo FX
    Adv Exp Med Biol; 1986; 195 Pt A():85-92. PubMed ID: 3728189
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic and immunologic evidence for a complete gene block in myoadenylate deaminase deficiency.
    Fishbein WN; Davis JI; Foellmer JW
    J Exp Pathol; 1983; 1(1):7-25. PubMed ID: 6086015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte AMP-deaminase: an investigation of the increase in activity during chick maturation.
    Kruckeberg WC; Marcus N; Lemley S; Chilson OP
    Comp Biochem Physiol B; 1978; 61(4):559-63. PubMed ID: 318390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
    Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
    J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate deaminase deficiency in a mutant murine T cell lymphoma cell line.
    Hanson S; McCartan K; Sabina RL; Holmes EW; Ullman B
    J Biol Chem; 1990 Jul; 265(20):11474-81. PubMed ID: 2365681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoadenylate deaminase deficiency: an enzyme defect in search of a disease.
    Joosten E; van Bennekom C; Oerlemans F; De Bruyn C; Oei T; Trijbels J
    Adv Exp Med Biol; 1984; 165 Pt A():85-9. PubMed ID: 6720421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.
    Skyllouriotis ML; Marx M; Bittner RE; Skyllouriotis P; Gross M; Wimmer M
    Pediatr Neurol; 1997 Jul; 17(1):61-6. PubMed ID: 9308979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.